$0.8392
0.045.15%
At close: -
$0.8550
0.021.88%
After Hours: 5:17 PM EDT
Comments
Loading...
Verrica Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:VRCA | Benzinga
Verrica Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 13
EPS Estimate
$-0.070
Quarterly Revenue Estimate
$4.37M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$7.18M
Analyze the earnings history of Verrica Pharmaceuticals using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
VRCA | Verrica Pharmaceuticals | -$0.31 | -$0.07 | — | — | $5.18M | $4.37M | — | — | 08/13/2025 | |
VRCA | Verrica Pharmaceuticals | -$0.38 | -$0.10 | -$0.08 | 42.86% | $3.83M | $2.51M | $3.44M | 35.93% | 05/13/2025 | |
VRCA | Verrica Pharmaceuticals | -$0.48 | -$0.26 | -$0.18 | 25.00% | $1.99M | $1.04M | $344.00K | -73.54% | 03/11/2025 | |
VRCA | Verrica Pharmaceuticals | -$0.32 | -$0.28 | -$0.43 | -16.22% | $2.92M | $6.00M | -$1.78M | -138.49% | 11/04/2024 | |
VRCA | Verrica Pharmaceuticals | -$0.21 | -$0.42 | -$0.31 | 26.19% | $182.00K | $4.37M | $5.18M | 18.47% | 08/14/2024 | |
VRCA | Verrica Pharmaceuticals | -$0.13 | -$0.40 | -$0.38 | 5.00% | $37.00K | $2.78M | $3.83M | 37.63% | 05/13/2024 | |
VRCA | Verrica Pharmaceuticals | -$0.14 | -$0.53 | -$0.53 | 0.00% | $68.00K | $910.00K | $1.99M | 118.46% | 02/29/2024 | |
VRCA | Verrica Pharmaceuticals | $0.07 | -$0.36 | -$0.32 | 11.11% | $8.32M | $510.00K | $2.92M | 471.96% | 11/09/2023 | |
VRCA | Verrica Pharmaceuticals | -$0.32 | -$0.21 | -$0.21 | 0.00% | $214.00K | $70.00K | $182.00K | 160.00% | 08/08/2023 | |
VRCA | Verrica Pharmaceuticals | -$0.25 | -$0.19 | -$0.13 | 31.58% | $431.00K | $430.00K | $37.00K | -91.40% | 05/09/2023 | |
VRCA | Verrica Pharmaceuticals | -$0.35 | -$0.19 | -$0.14 | 26.32% | $0.00 | $310.00K | $68.00K | -78.06% | 03/06/2023 | |
VRCA | Verrica Pharmaceuticals | -$0.47 | -$0.11 | $0.07 | 163.64% | $0.00 | $4.25M | $8.32M | 95.74% | 11/07/2022 | |
VRCA | Verrica Pharmaceuticals | -$0.35 | -$0.22 | -$0.37 | -68.18% | $0.00 | $310.00K | $214.00K | -30.97% | 08/11/2022 | |
VRCA | Verrica Pharmaceuticals | $0.03 | -$0.47 | -$0.25 | 46.81% | $12.00M | — | $431.00K | — | 05/09/2022 | |
VRCA | Verrica Pharmaceuticals | -$0.52 | -$0.50 | -$0.35 | 30.00% | $0.00 | — | $0.00 | — | 03/02/2022 | |
VRCA | Verrica Pharmaceuticals | -$0.42 | -$0.51 | -$0.47 | 7.84% | $0.00 | — | $0.00 | — | 11/12/2021 | |
VRCA | Verrica Pharmaceuticals | -$0.38 | — | -$0.43 | — | $0.00 | — | $0.00 | — | 08/10/2021 | |
VRCA | Verrica Pharmaceuticals | -$0.39 | — | -$0.04 | — | $0.00 | — | $12.00M | — | 05/07/2021 | |
VRCA | Verrica Pharmaceuticals | -$0.31 | — | -$0.52 | — | $0.00 | — | $0.00 | — | 03/04/2021 | |
VRCA | Verrica Pharmaceuticals | -$0.24 | — | -$0.42 | — | $0.00 | — | $0.00 | — | 11/09/2020 | |
VRCA | Verrica Pharmaceuticals | -$0.28 | — | -$0.38 | — | $0.00 | — | $0.00 | — | 08/05/2020 |
Verrica Pharmaceuticals (VRCA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-13 | $-0.08 | $-0.10 | 42.9 % |
| Q4 | 2025-03-11 | $-0.18 | $-0.26 | 25.0 % |
| Q3 | 2024-11-04 | $-0.43 | $-0.28 | -16.2 % |
| Q2 | 2024-08-14 | $-0.31 | $-0.42 | 26.2 % |
Verrica Pharmaceuticals (VRCA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-13 | $3.44M | $2.51M | 35.9 % |
| Q4 | 2025-03-11 | $344.00K | $1.04M | -73.5 % |
| Q3 | 2024-11-04 | $-1.78M | $6.00M | -138.5 % |
| Q2 | 2024-08-14 | $5.18M | $4.37M | 18.5 % |
FAQ
When is Verrica Pharmaceuticals (NASDAQ:VRCA) reporting earnings?
Verrica Pharmaceuticals (VRCA) is scheduled to report earnings on August 13, 2025. The last reported earnings were for reported on May 13, 2025 for Q1.
What were the latest earnings per share (EPS) for Verrica Pharmaceuticals (NASDAQ:VRCA)?
The Actual EPS was $-0.08, which beat the estimate of $-0.10.
What were Verrica Pharmaceuticals’s (NASDAQ:VRCA) revenues?
The Actual Revenue was $3.4M, which beat the estimate of $2.5M.
Browse earnings estimates, EPS, and revenue on all stocks.
